The global microRNA market was valued at $1.61 billion in 2023 and is projected to reach $6.11 billion by 2034, growing at a compound annual growth rate (CAGR) of 12.89% from 2024 to 2034. The increasing prevalence of chronic conditions, along with advancements in biotechnology, are key factors driving the market’s growth.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5211
MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression. In the biotechnology and life sciences industries, they are critical for developing diagnostic tools and therapies. miRNAs play a vital role in controlling gene expression involved in numerous illnesses, including cancer and infectious diseases. As biomarkers, microRNAs help identify the diagnostic, prognostic, and predictive values for patient management and are pivotal in the detection of diseases in tissues and bodily fluids.
Artificial Intelligence (AI) and machine learning are revolutionizing the microRNA market by improving the discovery and development of miRNA-based therapies. Machine learning techniques help identify new miRNA biomarkers and build high-performance classification models for disease detection, such as cancer. For instance, in July 2023, researchers developed a multiclass cancer detection tool using AI and microRNA, enhancing non-invasive diagnostic methods.
Leading companies in the microRNA market include:
Research into miRNAs as therapeutic targets has led to numerous clinical trials worldwide. A search of the Clinical Trials Database in January 2023 revealed 1,213 studies related to microRNA:
These clinical trials aim to explore miRNA’s potential in drug development, diagnosis, and screening across various human disorders.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/microrna-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5211
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The rheumatoid arthritis drugs market size achieved a value of USD 17.87 billion in 2023 with this trajectory, it is… Read More
The ambulatory surgical centers market accounted for USD 94.57 billion in 2022 and is predicted to increase to USD 167.1… Read More
The global dental services market accounted for USD 432.1 billion in 2022 and is expected to hit US$ 699.7 billion… Read More
The cell and gene therapy manufacturing market size is estimated for US$ 3,755.4 million in 2022 to reach an estimate… Read More
The global CAR T-Cell therapy market is estimated to grow from USD 3.87 billion in 2022 at 29.8% CAGR (2023-2032)… Read More
Overview The automotive electronic stability control system market was valued at USD 40.65 billion in 2022 and is expected to… Read More